NEWS

We are pleased to announce the publication of an exclusive interview between Isabelle Caron, CEO of the Biologics Manufacturing Centre (BMC), and Céline Chabet, partner at Kestria Canada & USA.

This exchange offers a unique insight into Isabelle Caron’s vision for the future of biomanufacturing in Canada and the strategies being deployed to strengthen the position of the BMC within the life sciences ecosystem.

In this inspiring discussion, they address essential themes such as innovation in biotechnology, the contribution of the BMC to the Canadian economy and the growth of the life sciences ecosystem, the importance of creating synergies, talent acquisition, and expanding the pool of qualified individuals.

Don’t miss this opportunity to discover the thoughts and perspectives of one of the key figures in biomanufacturing in Canada.